Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Progress in Cardiovascular Nursing|November 9, 2005
Thrombocytopenia following heparin flushIris McNulty, Eliezer Katz, Karissa Y Kim
Therapeutic Advances in Neurological Disorders|March 30, 2018
B cell-based therapies in CNS autoimmunity: differentiating CD19 and CD20 as therapeutic targetsThomas G Forsthuber, Daniel M Cimbora, John Nolan Ratchford, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 4, 2007
Argatroban therapy for heparin-induced thrombocytopenia in acutely ill patientsAnthony Gray, Diane E Wallis, Marcie J Hursting, et al.
Clinical Pharmacokinetics|October 31, 2021
Population Pharmacokinetic Modeling of Inebilizumab in Subjects with Neuromyelitis Optica Spectrum Disorders, Systemic Sclerosis, or Relapsing Multiple SclerosisLi Yan, Holly Kimko, Bing Wang, et al.
Transplantation|March 9, 2002
Benefits of chronic plasmapheresis and intravenous heme-albumin in erythropoietic protoporphyria after orthotopic liver transplantationKhoa D Do, Barbara F Banner, Eliezer Katz, et al.
Therapeutic Innovation & Regulatory Science|September 19, 2018
Statistical Considerations for an Adaptive Design for a Serious Rare DiseaseKaushik Patra, Bruce A C Cree, Eliezer Katz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 1, 2021
Long-term efficacy and safety of inebilizumab in neuromyelitis optica spectrum disorder: Analysis of aquaporin-4-immunoglobulin G-seropositive participants taking inebilizumab for ⩾4 years in the N-MOmentum trialMary Rensel, Aram Zabeti, Maureen A Mealy, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 17, 2002
Preemptive strategy for ganciclovir administration against cytomegalovirus in liver transplantation recipientsJennifer S Daly, Andrea Kopasz, Raji Anandakrishnan, et al.
British Journal of Clinical Pharmacology|March 25, 2022
Pharmacodynamic modelling and exposure-response assessment of inebilizumab in subjects with neuromyelitis optica spectrum disordersLi Yan, Bing Wang, Dewei She, et al.
Annals of Neurology|March 16, 2021
Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder BiomarkerOrhan Aktas, Michael A Smith, William A Rees, et al.
Pageof 4